Regenxbio Inc (RGNX)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -61,173 | -63,256 | 308,442 | 175,633 | -7,646 |
| Revenue | US$ in thousands | 85,585 | 89,470 | 446,639 | 291,249 | 59,562 |
| Gross profit margin | -71.48% | -70.70% | 69.06% | 60.30% | -12.84% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-61,173K ÷ $85,585K
= -71.48%
The gross profit margin of Regenxbio Inc has fluctuated over the past five years, ranging from a low of 51.61% in 2022 to a high of 89.46% in 2021. The 2023 gross profit margin stands at 58.76%, indicating a significant increase compared to the previous year. This improvement suggests that the company may have been able to effectively manage its production costs and increase the markup on its products or services. However, it is important to note that the gross profit margin can be influenced by various factors such as pricing strategies, input costs, and operational efficiencies. Further analysis of the company's financial performance and industry benchmarks would provide more insights into the drivers behind these fluctuations in the gross profit margin.
Peer comparison
Dec 31, 2023